Targeting aberrant learning may improve Parkinson's treatment

Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the ...
Science Daily

Parkinson’s breakthrough changes what we know about dopamine

A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly enables movement in the background, much like oil in an engine. When ...
Los Angeles Times

Parkinson’s Disease: What We Know and Where Treatment Is Headed

Parkinson’s disease affects over 10 million people globally, with incidence increasing after age 60. Dopamine-producing neuron loss leads to both motor and non-motor symptoms, including tremors, sleep ...

Scientists Say a Major Assumption About Parkinson’s Disease May Be Wrong

Researchers at McGill University have uncovered a surprising twist in how dopamine affects movement, overturning a ...
St. Louis Magazine

Kehoe’s veto of Parkinson’s disease registry frustrates advocates

For more than 200 years, ever since a British apothecary named James Parkinson in 1817 published “An Essay on the Shaking Palsy,” scientists have searched for the reasons why some people develop ...
News Medical

Van Andel Institute and Cure Parkinson's extend major Parkinson's drug trial initiative

Van Andel Institute and Cure Parkinson's have renewed a funding agreement to support the International Linked Clinical Trials Program, the world's largest drug repurposing clinical trial initiative ...

Brett Favre shares health update on battle with Parkinson's disease

Brett Favre shared an update on his health a year after revealing he was diagnosed with Parkinson's, saying he is in the ...

Brett Favre Has Basically Given Up Hope In His Battle With Parkinson’s Disease

Former NFL quarterback Brett Favre says he has basically given up hope in his ongoing battle with Parkinson's Disease. He believes a cure isn't coming ...